Enforcers should watch pharma rebates, Chopra says

Antitrust enforcers should scrutinise bundled rebates that drugmakers provide to payers, particularly when the rebates go to pharmacy benefit managers, Federal Trade Commissioner Rohit Chopra has said.

Get unlimited access to all Global Competition Review content